⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

December 6, 2021BloodOpen Access

Redefining nonmeasurable multiple myeloma using mass spectrometry

View Full Paper

Ask AI

Bookmark

Share

Abstract

A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Giles et al. (2021) studied this question.

synapsesocial.com/papers/6acafae99abf242d545dbb49 https://doi.org/10.1182/blood.2021013794

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurementOriginal Research · 2019 · 98 citations
2A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosisOriginal Research · 2019 · 29 citations
3Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myelomaOriginal Research · 2001 · 421 citations
4Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass SpectrometryOriginal Research · 2016 · 180 citations